Now in it’s 5th year, the annual National Pathology Forum shares recent developments in pathology and how these are contributing to improve Australian health.
The program will feature case studies on innovative testing methods in the fields of genetics, biobanking and PoCT for example. The highly interactive nature of the National Pathology Forum will allow delegates to network with each other and converse with the speakers asking questions as part of debates, industry roundtables, short workshops and panel discussions.
Join expert speakers from Government, state-based Departments of Health, public and private pathology, universities and hospitals across Australia to hear a vast number of the latest industry perspectives.
International Keynote Speaker
Dr. Martin Myers – Clinical Director of Pathology Services, Lancashire Teaching Hospitals, UK
- How new legislation is affecting pathology
- Should pathology be at the forefront of clinical service or back of house testing?
- Genetic testing
- Point of Care Testing
- Quality assurance and industry regulation
- Microbiology automation
- Pathology: front line clinical service or back office testing factory? – Ken Barr, Executive Director, SA Pathology
- Legislative updates affecting pathology – TBA
- Accreditation, licensing and standards – Associate Professor Tony Badrick, Member, National Pathology Accreditation Advisory Council (NPAAC) Point of care testing (PoCT)
- The importance of PoCT – Paul Cohen, General Manager: Operations, Royal College of Pathologists Australia, Quality Assurance Programs (RCPAQAP)
- Pathology: how to avoid running a video store – Len Moaven, Clinical Microbiologist, Laverty Pathology
- Encouraging industry growth and development – Andrew Goodsall, Healthcare Equity Research Analyst, UBS
- Changing technologies expanding pathology potential – Dr. Glenn Edwards, National Medical Director, St John of God (SJOG) Pathology
- Industry Analysis: The future of pathology – Sarina Fisher, Director: Health Economics and Policy, The Centre for International Economics
- Pathology in the UK, a road less travelled – Dr. Martin Myers, Clinical Director of Pathology Services, Lancashire Teaching Hospitals, UK
- Asia-Pacific focus: What can we learn from our region? – Associate Professor Anthony Landgren, Head Pathologist: General Pathology, Healthscope
- State perspectives: What’s happening now and where are we going? – Associate Professor Robert Heddle, Royal Adelaide Hospital (RAH) and Clinical Professor Dominic Mallon, University of Western Australia
- Building and measuring the value proposition in laboratory medicine – Dr. Beverley Rowbotham, Pathologist, Sullivan Nicolaides Pathology
- Biobanking in Australia: the cost and value equation – Lisa Devereux, President, Australasian Biospecimen Network Association (ABNA)
- Genetic testing – Dr. Melody Caramins, Head of Genetics, SDS Pathology (Specialist Diagnostic Services)
- Microbiology automation – Dr. Gillian Wood, Microbiologist, Austin Health
- The impact of molecular methods on Microbiological diagnosis – Dr. Miles Beaman, Director of Pathology, Infectious Diseases Physician and Clinical Microbiologist, Western Diagnostic Pathology
- Impact of the diabetes epidemic and changing guidelines on laboratory workload – Associate Professor Ken Sikaris, Director of Clinical Support Systems, Sonic Healthcare